Sanofi Aktie
WKN: 920657 / ISIN: FR0000120578
25.05.2016 14:59:34
|
Medivation Urges Stockholders To Reject Sanofi's Consent Solicitation
(RTTNews) - Medivation, Inc. (MDVN) urged its stockholders to reject Sanofi's attempt to replace the company's entire Board with hand-picked nominees through a proposed consent solicitation. Medivation expects to promptly file consent revocation materials with the U.S. SEC.
David Hung, CEO of Medivation, said: "The proposal to replace our existing directors with Sanofi's hand-picked nominees is simply a tactical maneuver to facilitate a transaction that will transfer value that rightly belongs to Medivation stockholders to Sanofi."
On April 29, 2016, the Medivation Board unanimously rejected Sanofi's non-binding proposal to purchase Medivation for $52.50 per share in cash.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medivation IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Medivation IncShsmehr Analysen
Aktien in diesem Artikel
Sanofi S.A. (spons. ADRs) | 45,40 | 2,71% |
|
Sanofi S.A. | 92,48 | 2,74% |
|